Isolation and characterization of equine amniotic membrane-derived mesenchymal stem cells

Recent studies have shown that mesenchymal stem cells (MSCs) are able to differentiate into multi-lineage cells such as adipocytes, chondroblasts, and osteoblasts. Amniotic membrane from whole placenta is a good source of stem cells in humans. This membrane can potentially be used for wound healing and corneal surface reconstruction. Moreover, it can be easily obtained after delivery and is usually discarded as classified waste. In the present study, we successfully isolated and characterized equine amniotic membrane-derived mesenchymal stem cells (eAM-MSCs) that were cultured and maintained in low glucose Dulbecco's modified Eagle's medium. The proliferation of eAM-MSCs was measured based on the cumulative population doubling level (CPDL). Immunophenotyping of eAM-MSCs by flow cytometry showed that the major population was of mesenchymal origin. To confirm differentiation potential, a multi-lineage differentiation assay was conducted. We found that under appropriate conditions, eAM-MSCs are capable of multi-lineage differentiation. Our results indicated that eAM-MSCs may be a good source of stem cells, making them potentially useful for veterinary regenerative medicine and cell-based therapy.

[1]  K. Kang,et al.  Isolation and Characterization of Canine Amniotic Membrane-Derived Multipotent Stem Cells , 2012, PloS one.

[2]  G. R. Van de Walle,et al.  Markers of stemness in equine mesenchymal stem cells: a plea for uniformity. , 2011, Theriogenology.

[3]  M. Najar,et al.  A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. , 2011, Stem cells and development.

[4]  K. Kang,et al.  Isolation and characterization of equine amniotic fluid-derived multipotent stem cells. , 2011, Cytotherapy.

[5]  D. Fauza,et al.  Amniotic and placental mesenchymal stem cell isolation and culture. , 2011, Methods in molecular biology.

[6]  F. Blanco,et al.  Isolation and characterization of mesenchymal stem cells from human amniotic membrane. , 2011, Tissue engineering. Part C, Methods.

[7]  M. Krampera,et al.  Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide. , 2010, Stem cells and development.

[8]  S. Strom,et al.  Isolation of amniotic mesenchymal stem cells. , 2010, Current protocols in stem cell biology.

[9]  M. Zatz,et al.  Isolation, Characterization, and Differentiation Potential of Canine Adipose-Derived Stem Cells , 2010, Cell transplantation.

[10]  C. A. Hussni,et al.  Isolation and immunophenotypic characterization of mesenchymal stem cells derived from equine species adipose tissue. , 2009, Veterinary immunology and immunopathology.

[11]  C. Kawcak,et al.  Evaluation of adipose‐derived stromal vascular fraction or bone marrow‐derived mesenchymal stem cells for treatment of osteoarthritis , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[12]  Marjolein C H van der Meulen,et al.  Mesenchymal stem cells and insulin‐like growth factor‐I gene‐enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[13]  V. Nurcombe,et al.  Wnt signaling controls the fate of mesenchymal stem cells. , 2009, Gene.

[14]  D. Hess,et al.  Amnion: A Potent Graft Source for Cell Therapy in Stroke , 2009, Cell transplantation.

[15]  高岡 真帆.  Sutureless amniotic membrane transplantation for ocular surface reconstruction with a chemically defined bioadhesive , 2009 .

[16]  O. Sorițău,et al.  Isolation and characterization of mesenchymal stem cells from the amniotic membrane. , 2009, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[17]  F. Farina,et al.  Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers , 2009, Histochemistry and Cell Biology.

[18]  M. Kesting,et al.  The Role of Allogenic Amniotic Membrane in Burn Treatment , 2008, Journal of burn care & research : official publication of the American Burn Association.

[19]  L. A. Dahlgren,et al.  Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. , 2008, American journal of veterinary research.

[20]  Toshio Miki,et al.  Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells , 2008, Stem cells.

[21]  Charles P. Lin,et al.  Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone , 2008, Nature Medicine.

[22]  K. Addicks,et al.  Isolation and characterization of bone marrow-derived equine mesenchymal stem cells. , 2007, American journal of veterinary research.

[23]  A. Nixon,et al.  Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  P. Thomsen,et al.  Isolation of mesenchymal stem cells from equine umbilical cord blood , 2007, BMC biotechnology.

[25]  R. Clemmons,et al.  Expression of neural markers on bone marrow-derived canine mesenchymal stem cells. , 2006, American journal of veterinary research.

[26]  Wei Huang,et al.  Isolation of mesenchymal stem cells from human placenta: Comparison with human bone marrow mesenchymal stem cells , 2006, Cell biology international.

[27]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[28]  O. Lee,et al.  Isolation of multipotent mesenchymal stem cells from umbilical cord blood. , 2004, Blood.